These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 1526416

  • 1. [Cost of a mass screening program for colorectal cancer using the occult blood test].
    Arveux P, Faivre J, Bedenne L, Durand G, Milan C, Milan C.
    Gastroenterol Clin Biol; 1992; 16(6-7):547-51. PubMed ID: 1526416
    [Abstract] [Full Text] [Related]

  • 2. [Preliminary results of a mass screening program for colorectal cancer].
    Bedenne L, Durand G, Faivre J, Milan C, Boutron MC, Arveux P, Colombier P, Klepping C.
    Gastroenterol Clin Biol; 1990; 14(2):140-5. PubMed ID: 2328881
    [Abstract] [Full Text] [Related]

  • 3. [General practitioners' experience in a mass screening campaign of colorectal cancers].
    Durand G, Arveux P, Milan C, Quelier C, Bedenne L, Faivre J.
    Cah Sociol Demogr Med; 1992; 32(2-3):191-205. PubMed ID: 1297544
    [Abstract] [Full Text] [Related]

  • 4. Cost-effectiveness analysis of two strategies for mass screening for colorectal cancer in France.
    Berchi C, Bouvier V, Réaud JM, Launoy G.
    Health Econ; 2004 Mar; 13(3):227-38. PubMed ID: 14981648
    [Abstract] [Full Text] [Related]

  • 5. Participants' characteristics in a French colorectal cancer mass screening campaign.
    Herbert C, Launoy G, Thezee Y, Maurel J, Richir B, Reaud JM, Ollivier V, Pegulu L, Valla A, Gignoux M.
    Prev Med; 1995 Sep; 24(5):498-502. PubMed ID: 8524725
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Screening of colorectal cancer.
    Winawer SJ.
    Surg Oncol Clin N Am; 2005 Oct; 14(4):699-722. PubMed ID: 16226687
    [Abstract] [Full Text] [Related]

  • 12. The reasons of general practitioners for promoting colorectal cancer mass screening in France.
    Berchi C, Dupuis JM, Launoy G.
    Eur J Health Econ; 2006 Jun; 7(2):91-8. PubMed ID: 16474967
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effects of promoting colorectal cancer screening on screening utilisation: evaluation of the German Campaign "Aktiv gegen Darmkrebs" (Action against Colorectal Cancer).
    Loss J, Eichhorn C, Nagel E.
    Z Gastroenterol; 2006 Nov; 44(11):1127-34. PubMed ID: 17115353
    [Abstract] [Full Text] [Related]

  • 19. High participation rates are not necessary for cost-effective colorectal cancer screening.
    Howard K, Salkeld G, Irwig L, Adelstein BA.
    J Med Screen; 2005 Nov; 12(2):96-102. PubMed ID: 15949121
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.